International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post‐MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee

BACKGROUND: The Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention (TRS2°P), a 0‐to‐9‐point system based on the presence/absence of 9 clinical factors, was developed to classify the risk of major adverse cardiovascular events (MACE) (a composite of cardiovascular death,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mok, Yejin, Ballew, Shoshana H., Bash, Lori D., Bhatt, Deepak L., Boden, William E., Bonaca, Marc P., Carrero, Juan Jesus, Coresh, Josef, D'Agostino, Ralph B., Elley, C. Raina, Fowkes, F. Gerry R., Jee, Sun Ha, Kovesdy, Csaba P., Mahaffey, Kenneth W., Nadkarni, Girish, Peterson, Eric D., Sang, Yingying, Matsushita, Kunihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064832/
https://www.ncbi.nlm.nih.gov/pubmed/29982232
http://dx.doi.org/10.1161/JAHA.117.008426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064832/
https://www.ncbi.nlm.nih.gov/pubmed/29982232
http://dx.doi.org/10.1161/JAHA.117.008426

Ejemplares similares